Chapter/Section Purchase

1 Study Coverage
1.1 Anti-Retroviral Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Protease Inhibitors
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Integrase Inhibitors
1.2.5 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
1.3 Market by Application
1.3.1 Global Anti-Retroviral Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hepatitis
1.3.3 HIV/AIDS
1.3.4 Herpes
1.3.5 Influenza
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Retroviral Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Retroviral Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Retroviral Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Retroviral Drugs Sales by Region
2.4.1 Global Anti-Retroviral Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Retroviral Drugs by Region (2023-2028)
2.5 Global Anti-Retroviral Drugs Revenue by Region
2.5.1 Global Anti-Retroviral Drugs Revenue by Region (2017-2022)
2.5.2 Global Anti-Retroviral Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Retroviral Drugs Sales by Manufacturers
3.1.1 Global Top Anti-Retroviral Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Retroviral Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Retroviral Drugs in 2021
3.2 Global Anti-Retroviral Drugs Revenue by Manufacturers
3.2.1 Global Anti-Retroviral Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Retroviral Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Retroviral Drugs Revenue in 2021
3.3 Global Anti-Retroviral Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Retroviral Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Retroviral Drugs Sales by Type
4.1.1 Global Anti-Retroviral Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Retroviral Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Retroviral Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anti-Retroviral Drugs Revenue by Type
4.2.1 Global Anti-Retroviral Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Retroviral Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Retroviral Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Retroviral Drugs Price by Type
4.3.1 Global Anti-Retroviral Drugs Price by Type (2017-2022)
4.3.2 Global Anti-Retroviral Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Retroviral Drugs Sales by Application
5.1.1 Global Anti-Retroviral Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Retroviral Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Retroviral Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anti-Retroviral Drugs Revenue by Application
5.2.1 Global Anti-Retroviral Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Retroviral Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Retroviral Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Retroviral Drugs Price by Application
5.3.1 Global Anti-Retroviral Drugs Price by Application (2017-2022)
5.3.2 Global Anti-Retroviral Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Retroviral Drugs Market Size by Type
6.1.1 North America Anti-Retroviral Drugs Sales by Type (2017-2028)
6.1.2 North America Anti-Retroviral Drugs Revenue by Type (2017-2028)
6.2 North America Anti-Retroviral Drugs Market Size by Application
6.2.1 North America Anti-Retroviral Drugs Sales by Application (2017-2028)
6.2.2 North America Anti-Retroviral Drugs Revenue by Application (2017-2028)
6.3 North America Anti-Retroviral Drugs Market Size by Country
6.3.1 North America Anti-Retroviral Drugs Sales by Country (2017-2028)
6.3.2 North America Anti-Retroviral Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Retroviral Drugs Market Size by Type
7.1.1 Europe Anti-Retroviral Drugs Sales by Type (2017-2028)
7.1.2 Europe Anti-Retroviral Drugs Revenue by Type (2017-2028)
7.2 Europe Anti-Retroviral Drugs Market Size by Application
7.2.1 Europe Anti-Retroviral Drugs Sales by Application (2017-2028)
7.2.2 Europe Anti-Retroviral Drugs Revenue by Application (2017-2028)
7.3 Europe Anti-Retroviral Drugs Market Size by Country
7.3.1 Europe Anti-Retroviral Drugs Sales by Country (2017-2028)
7.3.2 Europe Anti-Retroviral Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Retroviral Drugs Market Size by Type
8.1.1 Asia Pacific Anti-Retroviral Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Retroviral Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Retroviral Drugs Market Size by Application
8.2.1 Asia Pacific Anti-Retroviral Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Retroviral Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Retroviral Drugs Market Size by Region
8.3.1 Asia Pacific Anti-Retroviral Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Retroviral Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anti-Retroviral Drugs Market Size by Type
9.1.1 Latin America Anti-Retroviral Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anti-Retroviral Drugs Revenue by Type (2017-2028)
9.2 Latin America Anti-Retroviral Drugs Market Size by Application
9.2.1 Latin America Anti-Retroviral Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anti-Retroviral Drugs Revenue by Application (2017-2028)
9.3 Latin America Anti-Retroviral Drugs Market Size by Country
9.3.1 Latin America Anti-Retroviral Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anti-Retroviral Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Retroviral Drugs Market Size by Type
10.1.1 Middle East and Africa Anti-Retroviral Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Retroviral Drugs Market Size by Application
10.2.1 Middle East and Africa Anti-Retroviral Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Retroviral Drugs Market Size by Country
10.3.1 Middle East and Africa Anti-Retroviral Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Retroviral Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Cardionet
11.1.1 Cardionet Corporation Information
11.1.2 Cardionet Overview
11.1.3 Cardionet Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Cardionet Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cardionet Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Overview
11.2.3 GE Healthcare Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GE Healthcare Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GE Healthcare Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AstraZeneca Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Bristol-Myers-Squibb
11.5.1 Bristol-Myers-Squibb Corporation Information
11.5.2 Bristol-Myers-Squibb Overview
11.5.3 Bristol-Myers-Squibb Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bristol-Myers-Squibb Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bristol-Myers-Squibb Recent Developments
11.6 Gilead
11.6.1 Gilead Corporation Information
11.6.2 Gilead Overview
11.6.3 Gilead Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Gilead Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Gilead Recent Developments
11.7 Cardiac Science Corp.
11.7.1 Cardiac Science Corp. Corporation Information
11.7.2 Cardiac Science Corp. Overview
11.7.3 Cardiac Science Corp. Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cardiac Science Corp. Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cardiac Science Corp. Recent Developments
11.8 Cardiocom
11.8.1 Cardiocom Corporation Information
11.8.2 Cardiocom Overview
11.8.3 Cardiocom Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cardiocom Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cardiocom Recent Developments
11.9 Biotelemetry
11.9.1 Biotelemetry Corporation Information
11.9.2 Biotelemetry Overview
11.9.3 Biotelemetry Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Biotelemetry Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biotelemetry Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Corporation Information
11.10.2 GlaxoSmithKline Overview
11.10.3 GlaxoSmithKline Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GlaxoSmithKline Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Recent Developments
11.11 Roche
11.11.1 Roche Corporation Information
11.11.2 Roche Overview
11.11.3 Roche Anti-Retroviral Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Roche Anti-Retroviral Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Retroviral Drugs Industry Chain Analysis
12.2 Anti-Retroviral Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Retroviral Drugs Production Mode & Process
12.4 Anti-Retroviral Drugs Sales and Marketing
12.4.1 Anti-Retroviral Drugs Sales Channels
12.4.2 Anti-Retroviral Drugs Distributors
12.5 Anti-Retroviral Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Retroviral Drugs Industry Trends
13.2 Anti-Retroviral Drugs Market Drivers
13.3 Anti-Retroviral Drugs Market Challenges
13.4 Anti-Retroviral Drugs Market Restraints
14 Key Findings in The Global Anti-Retroviral Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer